Brief: Spago Nanomedical Q3 Sales SEK 14 Thousand
Oct 29 (Reuters) - Spago Nanomedical Q3 net income SEK -6.265 million. Q3 adjusted EPS SEK -0.02 Q3 operating expenses SEK -7.568 million
Recent news on Spago Nanomedical AB (publ)
See all newsBrief: Spago Nanomedical Announces Outcome Of Rights Issue
Brief: Spago Nanomedical Resolves On Rights Issue Of About SEK 16 Million
Sweden's Spago Nanomedical Q1 loss narrows
Brief: Spago Nanomedical Q1 Sales SEK 22 Thousand
Brief: Spago Nanomedical Says Tumorad-01 Study Meets Primary Endpoint Of Maximum Tolerated Dose